54 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.
Why Clover Health Stock Looks Poised To Smack Shorts: A Technical Analysis
Clover Health (NASDAQ: CLOV) is under r/WallStreetBets’ spotlight again after printing
Top 20 Trending Stocks On WallStreetBets As Of Thursday, Aug. 12, 2021 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Moderna (MRNA)
Palantir Technologies (PLTR)
eBay (EBAY)
Clover Health Investments (CLOV)
SoFi Technologies (SOFI)
Pfizer
Benzinga Pro’s Top 5 Stocks To Watch For Thursday, Aug. 12, 2021: DIS, CLOV, NIO, SSYS, BODY
Today's 5 Stock Ideas:
Disney (DIS) - Will report quarterly results after market close Thursday. Analysts expect earnings of $0.56 per share on sales of $16.8 billion.
Clover Health Investments
Why Clover Health Shares Are Surging Higher Today
Clover Health Investments Corp (NASDAQ: CLOV) is trading higher Thursday after the company announced better-than-expected second-quarter financial results and issued guidance above estimates.
30 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales.
Clover Health Becomes Top WallStreetBets Interest Again As It Reports Q2 Revenue Beat; These Are Other Top Trends
Clover Health Investments Corp.
Clover Health Q2 Takeaways: Revenue Beat, Guidance Raise And Clover Assistant Growth
Health care technology company Clover Health (NASDAQ: CLOV) reported second-quarter earnings Wednesday afternoon.
13 Stocks Moving In Wednesday’s After-Hours Session
Gainers
Sonos (NASDAQ: SONO) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
Clover Health Investments Q2 Sales $412.50M Beat $205.38M Estimate
Clover Health Investments (NASDAQ:CLOV) reported quarterly sales of $412.50 million which beat the analyst consensus estimate of $205.38 million by 100.85 percent.